Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
Eli Lilly plans to buy privately held Merida Biosciences for up to $2.88 billion in cash.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
